205 related articles for article (PubMed ID: 24942752)
1. Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors.
Ruggeri M; Tosetto A; Palandri F; Polverelli N; Mazzucconi MG; Santoro C; Gaidano G; Lunghi M; Zaja F; De Stefano V; Sartori R; Fazi P; Rodeghiero F;
J Thromb Haemost; 2014 Aug; 12(8):1266-73. PubMed ID: 24942752
[TBL] [Abstract][Full Text] [Related]
2. Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease-specific treatments: a French nationwide cohort study.
Lafaurie M; Maquet J; Baricault B; Ekstrand C; Christiansen CF; Linder M; Bahmanyar S; Nørgaard M; Sailler L; Lapeyre-Mestre M; Sommet A; Moulis G
Br J Haematol; 2021 Nov; 195(3):456-465. PubMed ID: 34386974
[TBL] [Abstract][Full Text] [Related]
3. Thrombosis in immune thrombocytopenia - current status and future perspectives.
Swan D; Newland A; Rodeghiero F; Thachil J
Br J Haematol; 2021 Sep; 194(5):822-834. PubMed ID: 33822358
[TBL] [Abstract][Full Text] [Related]
4. Risk of arterial thrombotic and venous thromboembolic events in patients with primary chronic immune thrombocytopenia: a Scandinavian population-based cohort study.
Nørgaard M; Cetin K; Maegbaek ML; Kristensen NR; Ghanima W; Bahmanyar S; Stryker S; Christiansen CF
Br J Haematol; 2016 Aug; 174(4):639-42. PubMed ID: 26456477
[No Abstract] [Full Text] [Related]
5. Evaluation of thrombotic events in patients with immune thrombocytopenia.
Ito S; Fujiwara SI; Ikeda T; Toda Y; Mashima K; Umino K; Minakata D; Nakano H; Yamasaki R; Kawasaki Y; Sugimoto M; Ashizawa M; Yamamoto C; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Kanda Y
Ann Hematol; 2020 Jan; 99(1):49-55. PubMed ID: 31853702
[TBL] [Abstract][Full Text] [Related]
6. Is ITP a thrombophilic disorder?
Rodeghiero F
Am J Hematol; 2016 Jan; 91(1):39-45. PubMed ID: 26547507
[TBL] [Abstract][Full Text] [Related]
7. [Thrombosis during thrombopoietin receptor agonist treatment for immune thrombocytopenia. A French multicentric observational study].
Weber E; Moulis G; Mahévas M; Guy C; Lioger B; Durieu I; Hunault M; Ramanantsoa M; Royer B; Default A; Pérault-Pochat MC; Moachon L; Bernard N; Bardy G; Jonville-Bera AP; Geniaux H; Godeau B; Cathébras P
Rev Med Interne; 2017 Mar; 38(3):167-175. PubMed ID: 27793553
[TBL] [Abstract][Full Text] [Related]
8. Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.
Zaja F; Barcellini W; Cantoni S; Carpenedo M; Caparrotti G; Carrai V; Di Renzo N; Santoro C; Di Nicola M; Veneri D; Simonetti F; Liberati AM; Ferla V; Paoloni F; Crea E; Volpetti S; Tuniz E; Fanin R
Am J Hematol; 2016 May; 91(5):E293-5. PubMed ID: 26910388
[TBL] [Abstract][Full Text] [Related]
9. [Antiphospholipid antibodies and the risk of thrombosis: a comparative survey between chronic immune thrombocytopenia and primary antiphospholipid syndrome].
Moulis G; Delavigne K; Huguet F; Fortenfant F; Beyne-Rauzy O; Adoue D
Rev Med Interne; 2011 Dec; 32(12):724-9. PubMed ID: 21864953
[TBL] [Abstract][Full Text] [Related]
10. Thrombosis in patients with immune thrombocytopenia: incidence, risk, and clinical outcomes.
Goncalves I; Lewis C; Grainger B; Dring R; Lee N; Pasricha SR; Szer J; Mason K
Res Pract Thromb Haemost; 2024 Jan; 8(1):102342. PubMed ID: 38444612
[TBL] [Abstract][Full Text] [Related]
11. [The incidence and risk factors for thrombosis in primary immune thrombocytopenia].
Huang YT; Liu XF; Chen YF; Fu RF; Liu W; Xue F; Zhang L; Yang RC
Zhonghua Xue Ye Xue Za Zhi; 2018 Nov; 39(11):942-946. PubMed ID: 30486593
[No Abstract] [Full Text] [Related]
12. Prevalence and correlates of thrombosis in adults with immune thrombocytopenia: An NIS study.
Machin N; Ragni MV; Comer DM; Yabes JG
Thromb Res; 2018 Dec; 172():80-85. PubMed ID: 30384039
[TBL] [Abstract][Full Text] [Related]
13. The use of thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): a "real life" retrospective multicenter experience of the Rete Ematologica Pugliese (REP).
Mazza P; Minoia C; Melpignano A; Polimeno G; Cascavilla N; Di Renzo N; Specchia G
Ann Hematol; 2016 Jan; 95(2):239-44. PubMed ID: 26596973
[TBL] [Abstract][Full Text] [Related]
14. The association between idiopathic thrombocytopenic purpura and cardiovascular disease: a retrospective cohort study.
Chandan JS; Thomas T; Lee S; Marshall T; Willis B; Nirantharakumar K; Gill P
J Thromb Haemost; 2018 Mar; 16(3):474-480. PubMed ID: 29297977
[TBL] [Abstract][Full Text] [Related]
15. Characteristics, risk factors and management of venous thromboembolism in immune thrombocytopenia: a retrospective multicentre study.
Le Guenno G; Guieze R; Audia S; Khellaf M; Michel M; Bonnotte B; Ruivard M; Godeau B
Intern Med J; 2019 Sep; 49(9):1154-1162. PubMed ID: 30816621
[TBL] [Abstract][Full Text] [Related]
16. Impact of risk factors on the occurrence of arterial thrombosis and venous thromboembolism in adults with primary immune thrombocytopenia - Results from two nationwide cohorts.
Ekstrand C; Linder M; Baricault B; Lafaurie M; Sailler L; Lapeyre-Mestre M; Kieler H; Moulis G; Bahmanyar S
Thromb Res; 2019 Jun; 178():124-131. PubMed ID: 31026663
[TBL] [Abstract][Full Text] [Related]
17. Massive intrasplenic arterial thrombosis in a patient with chronic ITP during the development of an Evans syndrome.
Diez-Feijóo R; Rodríguez-Sevilla JJ; Colomo L; Papaleo N; Maiques JM; Gimeno E; Andrade-Campos M; Abella E; Merchan BM; Calvo X; Jimenez C; Román-Bravo OD; Salar A; Sanchez-Gonzalez B
Thromb Res; 2021 Dec; 208():226-229. PubMed ID: 33714615
[TBL] [Abstract][Full Text] [Related]
18. Risk of thrombosis with thrombopoietin receptor agonists for ITP patients: A systematic review and meta-analysis.
Tjepkema M; Amini S; Schipperus M
Crit Rev Oncol Hematol; 2022 Mar; 171():103581. PubMed ID: 35007700
[TBL] [Abstract][Full Text] [Related]
19. Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis.
Doobaree IU; Nandigam R; Bennett D; Newland A; Provan D
Eur J Haematol; 2016 Oct; 97(4):321-30. PubMed ID: 27199203
[TBL] [Abstract][Full Text] [Related]
20. Thrombopoietin receptor agonists in patients with persistent or chronic immune thrombocytopenia.
Agnelli Giacchello J; Valeri F; Boccadoro M; Borchiellini A
Eur J Haematol; 2018 Mar; 100(3):304-307. PubMed ID: 29243329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
